Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Consortium identifies novel potential therapeutic targets for spinal cord repair

17.09.2004


Research funded by the Christopher Reeve Paralysis Foundation focuses on 108 genes



The study, involving the seven Consortium laboratories, characterized the changes in gene expression at the site of, as well as above and below, a moderate contusion injury in rats. The project involved 108 GeneChips and looked at four time points, spanning from three hours after injury to a more "chronic" state 35 days later. The data analysis produced a spatial and temporal profile of spinal cord injury and also identified several promising avenues for new clinical treatments. The study, the largest of its kind published to-date in the spinal cord field, is now available in the October issue of Experimental Neurology at http://dx.doi.org/10.1016/j.expneurol.2004.05.042.

The CRPF Research Consortium on Spinal Cord Injury is an international network of neuroscientists focused on repair and recovery of function in the chronically injured spinal cord. Through collaborative research, Consortium investigators are studying how to optimize the intrinsic capacity of the adult nervous system to repair and remodel itself as well as how to elicit robust regenerative responses after injury.


The Consortium is working with TopCoder (http://www.topcoder.com), a Glastonbury, CT company that organizes and hosts online and onsite programming competitions for a global community of members, to create a high-quality, web-based application to disseminate the microarray data from this study to the scientific community. This interactive platform, which will allow users to see how thousands of genes behave after injury, will be available at http://genechip.salk.edu/ shortly and will make data easily accessible to all scientists including those unfamiliar with GeneChip technology. CRPF believes that the database information will be highly relevant to researchers investigating many different aspects of spinal cord injury. Since the web application is still under development, temporary access to the study’s raw data and analyzed files is available now at http://genechip.salk.edu/.

"This is groundbreaking research," said Kathy Lewis, President and CEO of CRPF. "Consortium scientists are already moving forward to explore the therapeutic possibilities identified by the study."

Microarray technology has emerged as an exciting and aggressive tool that enables researchers to screen thousands of genes simultaneously to see which ones are active, or expressed, and which ones are silent. Genes are arrayed on a microchip the size of a fingernail, and experiments that once took years to complete can now be done in a relatively short time. The technology eliminates a lot of the guesswork that had been involved in gene profiling. Scientists believe that by observing the patterns of gene expression to see how they change after a spinal cord injury, they might identify therapeutic targets.

"Microarray technology gives us an unbiased ’snapshot’ of gene expression in many animals, including the mouse and rat, and humans. The approach enables biologists not only to explore gene changes after injury but also to look at genes that are changed by any experimental therapy. It is a powerful research tool," said Susan P. Howley, CRPF Executive Vice President and Director of Research.

The Christopher Reeve Paralysis Foundation (CRPF) is committed to funding research that develops treatments and cures for paralysis caused by spinal cord injury and other central nervous system disorders. The Foundation also vigorously works to improve the quality of life for people living with disabilities through its grants program, Paralysis Resource Center, and advocacy efforts. For more information on CRPF’s Research Consortium visit www.ChristopherReeve.org or contact Susan P. Howley at 800-225-0292, ext. 113.

Maggie Goldberg | EurekAlert!
Further information:
http://www.crpf.org

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>